People
James Wooldridge
James Wooldridge is published by SSI Strategy as Independent Executive Advisory Network member. Clinical drug developer with first-in-human and later-stage trial experience, published as Immunitas Therapeutics CMO.
Roles
SSI Strategy
CurrentIndependent Executive Advisory Network member